Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Cingulate Therapeutics See All Filings	D/A	2020-06-29 10:52:06 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers NONE CIK Number 0001593151 Filed Document 0001593151-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-06-29 10:52:06 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business KANSAS Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D/A	2019-07-03 12:28:07 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers NONE CIK Number 0001593151 Filed Document 0001593151-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-07-03 12:28:07 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business KANSAS Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D	2018-07-11 16:29:35 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers NONE CIK Number 0001593151 Filed Document 0001593151-18-000005 Exclusions or Exemptions 506b Accepted Date 2018-07-11 16:29:35 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business KANSAS Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D/A	2018-01-16 15:54:13 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers none CIK Number 0001593151 Filed Document 0001593151-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-01-16 15:54:13 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D/A	2017-05-02 17:06:59 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001593151 Filed Document 0001593151-17-000003 Exclusions or Exemptions 506b Accepted Date 2017-05-02 17:06:59 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D/A	2016-01-19 00:00:00 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001593151 Filed Document 0001593151-16-000001 Exclusions or Exemptions 506b Accepted Date 2016-01-19 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity
Cingulate Therapeutics See All Filings	D	2013-11-27 00:00:00 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001593151 Filed Document 0001593151-13-000001 Exclusions or Exemptions 506b Accepted Date 2013-11-27 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business NEW JERSEY Revenue or Assets $No Revenues Type of Security Equity